Frontiers in Immunology (Oct 2022)
Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes
- Camillo Bechi Genzano,
- Eugenia Bezzecchi,
- Eugenia Bezzecchi,
- Debora Carnovale,
- Alessandra Mandelli,
- Elisa Morotti,
- Elisa Morotti,
- Valeria Castorani,
- Valeria Favalli,
- Valeria Favalli,
- Angela Stabilini,
- Vittoria Insalaco,
- Francesca Ragogna,
- Valentina Codazzi,
- Giulia Maria Scotti,
- Stefania Del Rosso,
- Benedetta Allegra Mazzi,
- Maurizio De Pellegrin,
- Andrea Giustina,
- Andrea Giustina,
- Lorenzo Piemonti,
- Lorenzo Piemonti,
- Emanuele Bosi,
- Emanuele Bosi,
- Emanuele Bosi,
- Manuela Battaglia,
- Marco J. Morelli,
- Riccardo Bonfanti,
- Riccardo Bonfanti,
- Riccardo Bonfanti,
- Alessandra Petrelli
Affiliations
- Camillo Bechi Genzano
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Eugenia Bezzecchi
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Eugenia Bezzecchi
- Center for Omics Sciences, IRCCS Ospedale San Raffaele, Milan, Italy
- Debora Carnovale
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Alessandra Mandelli
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Elisa Morotti
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Elisa Morotti
- Department of Pediatrics, IRCCS Ospedale San Raffaele, Milan, Italy
- Valeria Castorani
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Valeria Favalli
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Valeria Favalli
- Department of Pediatrics, IRCCS Ospedale San Raffaele, Milan, Italy
- Angela Stabilini
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Vittoria Insalaco
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Francesca Ragogna
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Valentina Codazzi
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Giulia Maria Scotti
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Stefania Del Rosso
- Laboratory Medicine, Autoimmunity Section, IRCCS Ospedale San Raffaele, Milan, Italy
- Benedetta Allegra Mazzi
- Immuno-Hematology and Transfusion Medicine (ITMS), IRCCS Ospedale San Raffaele, Milan, Italy
- Maurizio De Pellegrin
- Pediatric Orthopedic and Traumatology Unit, IRCCS Ospedale San Raffaele, Milan, Italy
- Andrea Giustina
- Institute of Endocrine and Metabolic Sciences, IRCCS Ospedale San Raffaele, Milan, Italy
- Andrea Giustina
- Università Vita-Salute San Raffaele, Milan, Italy
- Lorenzo Piemonti
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Lorenzo Piemonti
- Università Vita-Salute San Raffaele, Milan, Italy
- Emanuele Bosi
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Emanuele Bosi
- Department of General Medicine, Diabetes and Endocrinology, IRCCS Ospedale San Raffaele, Milan, Italy
- Emanuele Bosi
- Università Vita-Salute San Raffaele, Milan, Italy
- Manuela Battaglia
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Marco J. Morelli
- Center for Omics Sciences, IRCCS Ospedale San Raffaele, Milan, Italy
- Riccardo Bonfanti
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- Riccardo Bonfanti
- Department of Pediatrics, IRCCS Ospedale San Raffaele, Milan, Italy
- Riccardo Bonfanti
- Università Vita-Salute San Raffaele, Milan, Italy
- Alessandra Petrelli
- Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy
- DOI
- https://doi.org/10.3389/fimmu.2022.1026416
- Journal volume & issue
-
Vol. 13
Abstract
An unbiased and replicable profiling of type 1 diabetes (T1D)-specific circulating immunome at disease onset has yet to be identified due to experimental and patient selection limitations. Multicolor flow cytometry was performed on whole blood from a pediatric cohort of 107 patients with new-onset T1D, 85 relatives of T1D patients with 0-1 islet autoantibodies (pre-T1D_LR), 58 patients with celiac disease or autoimmune thyroiditis (CD_THY) and 76 healthy controls (HC). Unsupervised clustering of flow cytometry data, validated by a semi-automated gating strategy, confirmed previous findings showing selective increase of naïve CD4 T cells and plasmacytoid DCs, and revealed a decrease in CD56brightNK cells in T1D. Furthermore, a non-selective decrease of CD3+CD56+ regulatory T cells was observed in T1D. The frequency of naïve CD4 T cells at disease onset was associated with partial remission, while it was found unaltered in the pre-symptomatic stages of the disease. Thanks to a broad cohort of pediatric individuals and the implementation of unbiased approaches for the analysis of flow cytometry data, here we determined the circulating immune fingerprint of newly diagnosed pediatric T1D and provide a reference dataset to be exploited for validation or discovery purposes to unravel the pathogenesis of T1D.
Keywords